Aligning Pharmaceutical Incentives with Health Outcomes

This chapter delves into a listener's proposal to revamp pharmaceutical taxation by aligning it with societal health outcomes. It highlights the importance of value-based care as a means to prioritize preventive measures and improve overall well-being in contrast to traditional healthcare models.